Meredith McDaniel, PA
Medical · Chattanooga, TNNPI 1871064113
Payments from drug & device makers
Across 501 payments — averaging $33.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Boston Scientific$1K
- Novartis$874
- Johnson & Johnson$723
- Medtronic$635
- Philips North America LLC$623
- plus $5K from 28 others
What the payments were for
- Consulting fees$1,5759%
- Travel & lodging$1,93812%
- Food & beverage$13,28179%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 159 | $7,215 |
| Boston Scientific | 25 | $1,343 |
| Novartis | 53 | $874 |
| Johnson & Johnson | 36 | $723 |
| Medtronic | 18 | $635 |
| Philips North America LLC | 39 | $623 |
| Abiomed | 5 | $549 |
| Boehringer Ingelheim | 21 | $546 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $394 |
| E.r. Squibb & Sons, L.L.C. | 17 | $389 |
| Atricure, Inc. | 3 | $338 |
| Biosense Webster, Inc. | 5 | $337 |
| Lexicon Pharmaceuticals, Inc. | 14 | $308 |
| Shockwave Medical, Inc | 2 | $277 |
| Novo Nordisk | 15 | $244 |
| Kestra Medical Technology Services, Inc. | 8 | $231 |
| Pfizer | 11 | $211 |
| AstraZeneca(2 entities) | 9 | $203 |
| Merck | 6 | $186 |
| Alnylam Pharmaceuticals Inc. | 9 | $180 |
| Inari Medical, Inc. | 1 | $145 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Amgen | 8 | $125 |
| Edwards Lifesciences | 1 | $103 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $89 |
| Bayer | 5 | $88 |
| Daiichi Sankyo Inc. | 4 | $70 |
| Azurity Pharmaceuticals, Inc. | 3 | $60 |
| Cardiva Medical, Inc. | 2 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Heartflow, Inc. | 1 | $35 |
| Bridgebio Pharma, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| GSK | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accent Pacemaker$2,494
- Confirm Rx$1,601
- Impella$301
- Carto 3$284
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$277
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$268
- WATCHMAN Access System$263
- JARDIANCE$248
- XARELTO$244
- WATCHMAN FLX$235
- ENSITE$186
- Farapulse$146
- FLOWTRIEVER CATHETER, S$145
- CT THROMBECTOMY SYSTEM KIT$145
- Assure WCD$134
- UPTRAVI$125
- OPSUMIT$125
- LINQ II$117
- PulseSelect$111
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$103
How this compares
$16,794 in reported general payments places this provider in the 95th percentile of 480 medical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 205 | $261,362 |
| EliquisApixaban | 150 | $181,878 |
| EntrestoSacubitril/Valsartan | 33 | $45,624 |
| Dofetilide | 90 | $37,486 |
| FarxigaDapagliflozin Propanediol | 14 | $11,677 |
| Flecainide Acetate | 74 | $3,387 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $3,296 |
| Metoprolol Succinate | 173 | $2,488 |
| Amiodarone Hcl | 87 | $2,374 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $1,450 |
| Colchicine | 14 | $1,253 |
| Rosuvastatin Calcium | 58 | $910 |
| Metoprolol Tartrate | 104 | $796 |
| Losartan Potassium | 71 | $729 |
| SotalolSotalol Hcl | 20 | $613 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $723 | $261,362205 claims |
| PfizerEliquis | $211 | $181,878150 claims |
| NovartisEntresto | $874 | $45,62433 claims |
| AstraZenecaFarxiga | $203 | $11,67714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 480 medical providers in Tennessee.
Other medical in Chattanooga
- Maria WoodChattanooga$130K
- Ginger MullinsChattanooga$9K
- Paul BatesChattanooga$8K
- Tiffany HayesChattanooga$5K
- Kirsten AndrewsChattanooga$5K
- Kaylee ChristensenChattanooga$5K
- Leona GulleyChattanooga$5K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.